openPR Logo
Press release

Helix Announces Medical Research Services In Asian Tiger Nations

03-21-2011 08:36 AM CET | Health & Medicine

Press release from: Helix Research Center Ltd

Clinical Research,Healthcare,Consulting,Training Worldwide

Clinical Research,Healthcare,Consulting,Training Worldwide

It is an established truth that the Four Asian Nations;Taiwan,Hongkong,South Korea and Singapore are considered highly developed economies and are known as Tiger or Dragon Countries.Though Hongkong and Singapore have emerged as International Finance Centers and Taiwan and South Korea are well know for their expertise in Information Technology,all these four Nations are more or less similar with reference to their Medical Research promotional endeavours.Inspired by the Policies of Ministries of Health and Regulatory Authorities,initiatives taken by various Professional Organisations and Research Community to promote New Drug Discovery and Ethical Clinical Research,Helix Research Center has taken an initiative to offer Medical Research and Educational Services for the Global Biopharmaceutical,Medical Device,Cosmetic Industry,Global Voluntary Organisations promoting Research and Development/Healthcare and Research Community of these Four Asian Tiger economies respectively.

The National Health Insurance system (NHI) in Taiwan assures Healthcare to all its Citizens and the National Health Research Institutes (NHRI) which is under direct supervision of Department of Health,People's Republic of China (PRC) has been working relentlessly to promote Healthcare and Medical Research.Most of the Hospitals across Taiwan have the potential to conduct Clinical Trials in any major Therapeutic area and the enthusiastic Medical Community is known for completing the Trials within the stipulated period of time.Taiwan has a huge pool of Life Sciences Graduates,Post Graduates and a substantial number of PhDs to work as Clinical Research Associates,Clinical Research Cooridnators and other support staff.Since Taiwan has a well developed Road,Rail and Air transport system,shipping of the Clinical Trial samples of Investigational New Products can be accomplishes with ease.

Hong Kong ,which is one of the Special Administrative Region of People's Republic of China is one of the densely populated country in Asia and one of the World's leading Financial Center.The oldest Institution of Tertiary Education;the University of Hongkong and many other Universities produce prospective support staff for the Clinical Research Investigators to expedite Phase 0 to IV,Pre Clinical or Bioavailability and Bio Equivalence (BA/BE) Studies for any Global Sponsor.Highly developed and Sophisticated Public/Private transport network in Hong Kong facilitates quicker commutering by Public and also hassle free transport of Medical supplies/Clinical Trial samples.The Continual efforts of Food and Health Bureau,the Hospital Authority;Government of Hong Kong,the Hong Kong Association of the Pharmaceutical Industry (HKAPI),the Hong Kong Private Hospitals Association and various other Professional Associations to promote Healthcare,Medical Research and R&D initiatives have created congenial and highly Professional environment for conducting Global Clincal Trials.

Being the Member of OECD ( Organisation for Economic Co operation and Development) countries,South Korea has emerged as one of the preferred destinations for Global Clinical Trials.The Slogan of Ministry of Health and Welfare,Government of Korea' The People's Voice is the Voice of Heaven' and the 'Online Government Services' available for any Citizen of South Korea,the efforts of the Ministry to provide Quality Healthcare to all its Citizens is praiseworthy indeed.The efforts of Korean Food and Drug Administration (KFDA) to ensure Safety of Clinical Trial Subjects by providing necessary Guidelines for Conducting Clinical Trials is remarkable.South Korea has substantial number of Life Life Sciences aspirants,Doctors,Nurses and Scientists to expedite a Clinical Research Project under strict GCP ( Good Clinical Practices ) Compliance.The Rapid Transit Subways and other means of Transport of in South Korea are of International standard.,

Being one of the World's leading Financial Center,with diverse population,Singapore has emerged as one of leading destinations for Global Clinical Trials.The Healthcare delivery in Singapore is accomplished by Public( National Healthcare Group-NHG and Singapore Health Services-SHS) and state of the art Private Healthcare systems.Singapore is one the World's favored Medical Tourism Centers.The efforts and multipronged approach of National Medical Research Council (NMRC),established by Ministry of Health,Singapore ,inroder to promote Ethical Research,R&D endeavours etc is a Role Model for many countries indeed.The Spohisticated Road,Rail,Air Transport System in Singapore is most convenient for Clinical Supplies/Clinical Trial sample shipping.The highly qualified and Trained Doctors of various Specialties strive hard to expedite their Clinical Research Projects within Timelines.

Helix Research Center will provide entire spectrum Scientific and Therapeutic Research Services for the Global Clinical Trial Sponsors and also Short Term Clinical Research Vocational Training Courses.The promoters of Helix Research Center always keep away from 'Competition' ,'Conflict of Interest' etc and embrace 'Cooperation,Collaboration,Ergonomics' etc.Further,Helix is keen to get associated with like minded Professionals,Associations,Institutions in any part of the World,inorder to promote New Drug Discovery,Preventive and Curative Healthcare.Since there is a dire need for Interpretation of GCPs Pan World,Helix has taken an initiative to Organise Seminars and Conferences in different regions of the World .

Helix Research Center Ltd is a London,UK Headquartered MNC,providing Clinical Research,Healthcare,Consulting,Training Services for the Biopharmaceutical,Medical Device,Cosmetic Industry,Global Voluntary Organisations promoting Healthcare/New Drug Discovery etc in Asia,Africa,Oceania,Europe,South America and North America

Helix Research Center Ltd,
Office 4,
219 Kensington High Street,
W8 6BD
London,England
UK

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Helix Announces Medical Research Services In Asian Tiger Nations here

News-ID: 167303 • Views: 1022

More Releases from Helix Research Center Ltd

Clinical Research Practices Concept to Expedite Global Clinical Trials
Having analysed and understood the Non Clinical & Clinical Trial outsourcing trends in the Global Clinical Research arena and the challenges by being endured by the stakeholders of Research & Development Industry;Viz the Pharmaceutical,Medical Device,Biotechnology and Cosmetic Industry Worldwide , the issues such as Financial constraints,safety and well being of Trial subjects,Errors,Misconducts,negative talk about the Clinical Trial activity itself in one or the other media and the need for introducing
Harmonised GCP Training Courses Launched by Helix Research Center
Inspired by the initiative of Sponsors of ICH ( International Conference on Harmonisation of Technical Requirements for the Registration of Pharmaceuticals of Human Use) Viz,European Agency for the Evaluation of Medicinal Products ( EMEA),Japanese Ministry of Health,Labour and Welfare (JMHLW) and the US Food and Drug Administration (USFDA) , the Co Sponsors;Viz ,the European Federation of Pharmaceutical Industries' Associations (EFPIA),the Japanese Pharmaceutical Manufacturers Association (JPMA),the Pharmaceutical Research and Manufacturers of
Clinical Research Certificate Programs With Internship In India
It is an established fact that Clinical Research Industry is considered multibillion dollar industry and there can be no 'Recession' for the rapidly increasing dreadful diseases that cause high mortality and morbidity in almost every region of the World,irrespective any global economic slowdown/recession. But the Global Biopharmaceutical ,Medical Device and Cosmetic Industry and other Sponsors of R&D ( Research and Development) have been enduring many constraints including severe financial
Consulting,SMO & Site Support Services for the Global Clinical Trials
In view of the absolute necessity to ensure ,Safety and well being of Clinical Trial Subjects ,strict adherence to Good Clinical Practices Guidelines and Regulations governing Biomedical Research by Doctors of various Therapeutic areas such as Cardiology,Neurology,Oncology,Endocrinology,Pulmonology,Psychiatry,Obstetrics & Gynecology,Gastroenterology,Opthalmology,ENT,Internal Medicine,General Surgery etc,the need to produce quality data for a given study,reduce Regulatory delays,prevent avoidable errors and misconducts during a Clinical Trial,reduce the avoidable overheads for the Clinical Trial Sponsors such

All 5 Releases


More Releases for Clinical

Clinical solutions
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Clinical Trial Management System
According to a new market report published by Persistence Market Research “Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019” the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017
Clinical Nutrition Conference 2018
Clinical nutrition is essential for patients in healthcare to deal with sickness, injuries, surgery and for proper recovery. It helps in preventing malnutrition, restoring body tissue and boosting energy and immunity in the body. It can be provided with a proper diet plan and feeding the patient with essential foods that revive the patient’s body the patient can also be given healthy supplements for proteins, vitamins etc. The preferred route
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
Europe Clinical Nutrition Market
According to the report “Europe Clinical Nutrition Market,” published by Market Data Forecast, the global market is projected to reach USD 12.45 billion by 2021 from USD 9.65 billion in 2016, at a CAGR of 5.29% from 2016 to 2021. Clinical nutrition is the practice of analysing if a person is consuming an adequate amount of nutrients for good health. A clinical nutritionist is concerned with how nutrients in food are